Clinical Trial Update: Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update evaluates sunitinib in patients with metastatic or locally advanced renal cell carcinoma who are not candidates for curative …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Spanish Oncology Genito-Urinary Group | Conditions: Carcinoma Renal Cells | Phase 2 | Status: COMPLETED